Sort
15,273 grants matching “antimicrobial resistance”
Contact Activation and Infection
$553,057Owen J McCarty · Oregon Health & Science University · R01 · FY2023 · AI
Modeling Health System Infectious Disease Data
$552,778Richard Platt · Harvard Pilgrim Health Care, Inc. · U01 · FY2008 · GM
Development of Paratransgenic Ticks for Disease Control
$552,726Ulrike Gertrud Munderloh · University Of Minnesota · R01 · FY2021 · AI
The role of CD40L in resistance to enteric infection
$552,706Christopher A Hunter · University Of Pennsylvania · U01 · FY2022 · AI
Biomarkers for Urinary Tract Infection and Pyelonephritis
$552,065Nader Shaikh · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Single dose azithromycin to prevent cholera in children
$551,975Jason B Harris · Massachusetts General Hospital · R01 · FY2024 · HD
Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition
$551,936Patricia Pavlinac · University Of Washington · R01 · FY2023 · HD
Discovering Antimicrobial Drugs from Symbiotic Actinobacteria from Terrestrial
$551,928Cameron Robert Currie · University Of Wisconsin-Madison · U19 · FY2017 · AI
The protease network that regulates innate immunity in mosquitoes
$551,792Kristin Michel · Kansas State University · R01 · FY2021 · AI
Survival of Neisseria gonorrhoeae after primary human neutrophil challenge
$551,645Alison K Criss · University Of Virginia · R01 · FY2020 · AI
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno
$551,410David Alan Mead · Lucigen Corporation · R44 · FY2014 · AI
Novel vaccine antigens against N. gonorrhoeae
$551,279Paola Massari · Tufts University Boston · R01 · FY2023 · AI
TH17 cells in AIDS pathogenesis and HIV vaccines
$551,253Mirko Paiardini · University Of Pennsylvania · R01 · FY2009 · AI
The role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelope
$550,423Michael Stephen Trent · University Of Georgia · R01 · FY2025 · AI
Pneumococcal Biofilms in Otitis Media
$550,403Allegheny-Singer Research Institute · R01 · FY2004 · DC
RISK FACTORS FOR DRUG RESISTANT PNEUMOCOCCAL PNEUMONIA
$550,247University Of Pennsylvania · R01 · FY2001 · AI
P Gingivalis LPS: Hemin-induced lipid A structural remodelling
$550,243Richard Peters Darveau · University Of Washington · R01 · FY2014 · DE
Methods to synthesize oligosaccharide-fusion protein conjugates and enhancement of their antigenicity
$550,227Steven Sucheck · University Of Toledo · R01 · FY2020 · AI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA
$550,162Brian James Werth · University Of Washington · R01 · FY2025 · AI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA
$550,162Brian James Werth · University Of Washington · R01 · FY2023 · AI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA
$550,162Brian James Werth · University Of Washington · R01 · FY2024 · AI
Modeling of infectious network dynamics for surveillance, control and prevention enhancement (MINDSCAPE)
$550,000Travis Christian Porco · University Of California, San Francisco · U01 · FY2020 · CK
Inference, Forecasting and Optimal Control of Healthcare-Associated Infections
$550,000Jeffrey L Shaman · Columbia University Health Sciences · U01 · FY2020 · CK
Modeling of infectious network dynamics for surveillance, control and prevention enhancement (MINDSCAPE)
$550,000Travis Christian Porco · University Of California, San Francisco · U01 · FY2022 · CK
Multi-scale modeling and phylodynamics for healthcare associated infections
$550,000Cristina Lanzas · North Carolina State University Raleigh · U01 · FY2020 · CK